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UNIT A1.3Extracranial Carotid Artery Disease
Magnetic resonance angiography (MRA) is a noninvasive means by which to study the
integrity of the vascular system (Potchen et al., 1992; Anderson et al., 1993).
This unit presents two MRA techniques for imaging the carotid arteries, time-of-flight
MRA (see Basic Protocol 1) and contrast-enhanced MRA (see Alternate Protocol). As a
complement to MRA, following either of the preceding two procedures, high-resolution
spin-echo scanning can be used to study the vessel wall in more detail (see Basic Protocol
2). The parameters given here are derived from experience at 1.5 T and may need to be
altered slightly depending on the field strength and the equipment manufacturer. In
particular, optimal TE may vary with different field strength.
BASIC
PROTOCOL 1
IMAGING THE CAROTID ARTERIES BY TIME-OF-FLIGHT MRA
Magnetic resonance angiography (MRA) scans can be run at a range of field strengths
with varying degrees of success. The high signal-to-noise ratio (SNR) obtained at a
high-field strength makes it possible to run the MRA scans either faster or with higher
resolution than at lower fields. (Low-field strength is generally ≤0.2 T, mid-field strength
is between 0.5 T and 1 T, and high-field strength is ≥1.5 T.) At low-field strengths,
contrast-enhanced MRA (see Alternate Protocol) may give better results than conven-
tional time-of-flight (TOF) MRA. The sequences described herein are based on the
authors’ experience with a Siemens 1.5 T Vision scanner, but are expected to be equally
applicable to machines from other manufacturers.
The following three sequences comprise the preferred protocol. In cases where a patient
requires a faster procedure (e.g., for trauma patients or those intolerant to a long scanning
session), either the two-dimensional (2-D) sequence (sequence 2) or the three-dimen-
sional (3-D) sequence (sequence 3) may be omitted. Because the 3-D sequence offers
higher through-plane resolution (1 mm) than the 2-D sequence, some radiologists and
researchers have suggested that 3-D techniques are more accurate than 2-D techniques in
detecting carotid stenosis. However, in older patients, for whom flow can be very slow,
the 2-D sequence may give better results. For patients with tortuous vessels, the contrast-
enhanced method (see Alternate Protocol) may be most appropriate. If desired, this
procedure may be followed by high-resolution spin-echo scanning (see Basic Protocol 2)
for a more detailed view of vessel walls. The entire Basic Protocol 1 takes ∼40 min.
Table A1.3.1 lists the hardware necessary to perform the procedure, along with appropri-
ate parameters. The available gradient strength will depend on the scanner, and the echo
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Table A1.3.1 Equipment Parameters for Time-of-Flight MRA
Coil type Circularly polarized neck coil or
neuro-vascular coil (or phased-array neck
coil, if available)
Gradient coil strength 25 mT/m (or whatever the system permits)
Cardiac gating No
Peripheral gating For safety only
Respiratory gating No
Respirator If required by patient
Oxygen If required by patient
Motion cushions Useful
Use of contrast agents Only use in the Alternate Protocol
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times given below may be varied accordingly (the lower the gradient strength, the longer
the echo time for a particular scan).
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
Set up patient and equipment
1. Interview (screen) the patient to ensure that he or she has no contraindications such
as cardiac pacemakers or other implants containing ferromagnetic materials that may
be problematic for patient safety or good image acquisition. Also be sure to find out
if the patient has any health conditions that may require the presence of special
emergency equipment during the scanning procedure, or necessitate any other pre-
cautions.
Generally, standard screening forms (APPENDIX 1) are used for all patients scanned in a
magnetic resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(2001) for a discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing,
as well as other items as described above.
2. If the procedure is a research protocol, have the patient sign any necessary consent
forms.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earplugs, earphones, or headphones are used to protect the ears from the loud
sounds produced by the gradients, the patient will be asked to wear one of these
devices, but will be able to communicate with you at any time during the imaging.
b. The patient may be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results, the patient should not talk, and should avoid or minimize
swallowing or other movement during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. Have the patient mount onto the table. Either before or right after the patient lies
down, set up any triggering devices or other monitoring equipment that is to be used.
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7. Center the patient in a neck coil, or a neuro-vascular coil, at the region where the key
information is desired. Make sure that the head and neck are constrained to prevent
motion, especially if high-resolution scans are to be run.
Generally, the patient’s head and neck are fixed so that they are horizontal (not tilted) and
lie along the axis of the patient table; other positions may be appropriate depending on
the imaging needs.
Most scanners have a special neck coil or a neuro-vascular coil for MRA; otherwise, a
head coil and/or cervical spine coil should be used and the patient placed so that the
bifurcation of the main carotid artery into the internal and external carotid arteries can be
imaged.
8. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
9. Use the centering light to position the patient at the angle of the mandible and put the
patient into the center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then returned to the same position as before without
jeopardizing the positioning of one scan relative to another.
10. If the patient is unable to hold still, provide an appropriate sedative.
Sequence 1: Rapid three-plane positioning pilot
11. To validate the patient’s position, run the system’s pilot (or scout) scan to ensure
correct location of the neck in three dimensions using the imaging sequence given in
Table A1.3.2 or similar parameters. Refer to manufacturer specifications for standard
default settings and swap as necessary.
This sequence usually consists of three orthogonal planes to allow localization. The images
are often also used later to determine where to place the saturation pulses and to set up
total coverage of the volume of interest.
Sequence 2: 2-D time-of-flight MRA
12. Bring the sequence for a rapid 2-D transverse scan up onto the console. Set the
imaging parameters as shown in Table A1.3.3.
13. Use the pilot (scout) images run earlier (sequence 1) to locate the vessel positions in
three dimensions and ensure coverage of the region of interest. Specifically, make
sure the carotid bifurcation is in the center of the field of view. Use the pilot images
to set up either a saturation pulse caudally to suppress signal from the incoming
arterial flow or cephalically (cranially) to suppress signal from the incoming venous
flow (see Fig. A1.3.1).
See Potchen et al. (1992), Anderson et al. (1993), and Haacke et al. (1999) for details of
setting up a saturation pulse.
The system usually applies this as a traveling saturation pulse to continue to saturate
venous flow near the plane being imaged but not so close as to interfere with application
of the usual slice selection process.
14. Let the patient know you are ready, and begin the scan.
Data processing and viewing for sequence 2
15. If a better view of the images is necessary, modify the window and level settings and
obtain a close-up view of a region by zooming in on the data (images). For example,
if a stenosis appears in the image that needs to be measured, zoom in on the image
by at least a factor of 2 and then use the distance function in the manufacturer’s
software to determine the width of the stenosis. This can then be compared to a more
normal portion of the vessel, if possible, either distal to the stenosis (NASCET
criteria) or proximal to the stenosis.
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Table A1.3.2 Primary Clinical Imaging Parameters for Sequence 1 (Pilot Scan)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Sagittal/coronal/transverse (many
scanners are now capable of triple
plane orthogonal scouts)
Central slice or volume center Laser light centered on edge of jaw
Echo time (TE) As short as possible (e.g., 6 msec)
Repeat time (TR) As short as possible (e.g., 15 msec)
Flip angle (FA) 15°
Fields of view (FOVx, FOVy) 300 mm, 300 mm
Resolution (∆x, ∆y) 1 mm, 1 mm
Number of data points collected (Nx, Ny) 300, 300
Slice thickness (∆z) 8 mm
Number of slices 3
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding Standard default
Slice locations Not applicable
Saturation pulses Not applicable
Scan time 16 sec
Table A1.3.3 Primary Clinical Imaging Parameters for Sequence 2 (2-D TOF)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Centered on the carotid bifurcation
Echo time (TE) As short as possible (usually <7 msec)
Repeat time (TR) 25 msec
Flip angle (FA) 35°
Fields of view (FOVx, FOVy) 256 mm, 160–200 mm
Resolution (∆x, ∆y) 1 mm, 1–1.25 mm or 0.5 mm, 1–1.25
mm
Number of data points collected (Nx, Ny) 256, 160 or 512, 160
Display matrix (Dx, Dy) 512, 512
Slice thickness (∆z) 2–3 mm
Number of slices 50–70, or as many as needed to cover
the region of interest
Slice gap –0.33 mm (overlapping)
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Slice locations Carotid bifurcation or stenosis
Saturation pulses Yes; cephalically (cranially) thick slab
to saturate veins or caudally thick slab
to suppress arteries
Slice series Ascending or descending, but not
interleaveda
Scan time ∼5 min
aThis will help eliminate reconstruction artifacts.
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Figure A1.3.1 Schematic of the carotid artery and jugular vein. The images resulting from the 3-D
TOF scan (sequence 3; Fig. A1.3.2) show dramatically reduced signal from the veins.
A B
DC
Figure A1.3.2 Transverse and coronal planes of a human neck. (A) A transverse image across the neck
without a saturation pulse shows a cross-section of both the carotid artery and the jugular vein (arrows). (B)
After a saturation pulse, the signal from the jugular vein is dramatically suppressed. (C, D) Coronally reformatted
images obtained from the same 3-D transverse data sets used to obtain the images shown in (A) and (B),
respectively. Note that the internal jugular veins (arrows) have vanished in (B) and (D).
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This zoom feature is only useful if it is done by interpolation of the images, not by pixel
duplication. Ideally, this should be done in the in-plane view, but if this is not available or
the data cannot be manipulated using multiplanar reformatting, a through-plane view
through the center of the vessel can be substituted.
16. Once the scan is complete, process the data as needed to produce a maximum intensity
projection (MIP) image (UNIT B7.3) of the vessels at different angles.
The resulting projections can then be viewed as a cine or movie loop to allow the physician
to obtain a more global perspective of the vasculature. If there are questions of accuracy
associated with this processing, go back and view the pristine data by reexamining the
original images or by slicing the original data in a transverse mode (or the view that gives
the best cross-sectional information) via a multiplanar reformatting to better view the
cross-section of the vessel of interest.
Sequence 3: 3-D time-of-flight MRA (Fig. A1.3.2)
17. Review the pilot scans and ensure that the saturation pulse is correctly placed above
the slab of interest.
18. Run the 3-D scan using parameters as close as possible to those in Table A1.3.4 to
obtain high signal from the arteries.
This sequence is usually performed in a transverse mode to benefit from a maximum inflow
effect.
19. Process the data from sequence 3 similar to that for sequence 2 (see steps 15 and 16).
Table A1.3.4 Primary Clinical Imaging Parameters for Sequence 3 (3-D TOF)a
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Centered on the carotid bifurcation
Echo time (TE) As short as possible; but using 7 msec
or 2.5 msec to 3.0 msec ensures that
water and fat are out of phase
Repeat time (TR) 20–40 msec
Flip angle (FA) 15°–25°
Fields of view (FOVx, FOVy) 256 mm, 160 mm
Resolution (∆x, ∆y) 1 mm, 0.83 mm
Number of data points collected (Nx, Ny) 512, 192
Display matrix (Dx, Dy) 512, 512
Slice thickness (∆z) 1 mm
Number of slices 64
Slab thickness 64 mm
Slice gap −0.38 mm (overlapping)
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Slice locations Carotid bifurcation or stenosis
Saturation pulses Yes; 50 to 80 mm thick slabs
cephalically (cranially) to saturate
veins or caudally to suppress arteries
Fat suppression Yes
Scan time ∼4–8 min
aNeed RF spoiled pulse.
Supplement 7 Current Protocols in Magnetic Resonance Imaging
A1.3.6
Extracranial
Carotid Artery
Disease
ALTERNATE
PROTOCOL
IMAGING THE CAROTID ARTERY BY CONTRAST-ENHANCED
TIME-OF-FLIGHT MRA
The set of imaging sequences presented in Basic Protocol 1 often suffices to reveal the
necessary angiographic information. However, the accuracy of non-contrast-enhanced
MRA is only slightly better than that of an ultrasound. For slow-flow cases, to obtain
better coverage or higher resolution, or where speed is of the essence (such as for elderly
patients, trauma patients, or patients who are uncooperative), an alternative procedure
using a T1-reducing contrast agent is preferred (Prince et al., 1997; Wilman et al., 1998).
This can be considered a supplementary approach, but in the near future, it is anticipated
that this contrast-enhanced (CE) sequence will eventually replace sequences 2 and 3
described in Basic Protocol 1. If desired, this procedure may be followed by high-reso-
lution spin-echo scanning (see Basic Protocol 2) to obtain a more detailed view of vessel
walls. The entire Alternate Protocol takes ∼25 min.
Materials
Gadolinium-based MR contrast agent (e.g., Magnevist, Omniscan, or Prohance)
Normal saline (0.9% NaCl), sterile
Power injector
Set up patient and equipment
1. Set up patient as in Basic Protocol 1, steps 1 to 6.
2. Establish an i.v. line from which the contrast agent can be injected, and attach this
line securely to the patient so that movement into or out of the magnet will not pull
at the patient’s arm.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet, so
that there is no intervening motion between the scans run before contrast agent injection
and those run after injection.
3. Repeat Basic Protocol 1, steps 7 to 10. Depending on the coverage required, use a
neck coil, a neuro-vascular coil, a phased-array head and neck coil, or the body coil.
Run pilot scan
4. Repeat a rapid three-plane positioning pilot scan by running sequence 1 (see Basic
Protocol 1).
Sequence 4: Short TR gradient echo timing bolus scan
The timing of the contrast bolus can be critical. Image acquisition should occur during
the first pass of the bolus, coinciding with arterial enhancement before arrival into adjacent
veins. Ideally, the filling of central k-space should occur during peak arterial enhancement.
Circulation times can vary widely among patients although bolus arrival times in the
carotid arteries generally occur 15 to 20 sec after initiation of the bolus. This can be
calculated by using a timing run with a small test bolus of contrast agent measured by a
single slice fast 2-D gradient echo sequence that acquires an image approximately every
second over the duration of the circulating bolus. Some newer scanners are also capable
of real-time “fluoroscopic MR imaging,” which allows the contrast-enhanced MRA
sequence to be manually triggered immediately after the fast 2-D sequence upon obser-
vation of peak arterial enhancement. For both injections, a power injector should be used
to deliver the solutions at a rate of 2 to 3 ml/sec.
5. Prepare the injector for a dose of 1 to 2 ml of contrast agent to be followed by a 15
to 20 ml bolus of saline flush.
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Table A1.3.5 Primary Clinical Imaging Parameters for Sequence 4 (Timing Bolus
Scan)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Centered on the carotid bifurcation
Echo time (TE) 2.3 msec
Repeat time (TR) 4.5 msec
Flip angle (FA) 8°
Fields of view (FOVx, FOVy) 350 mm, 262 mm
Resolution (∆x, ∆y) 1.37 mm, 1.36 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 1
Slice gap N/A
Number of acquisitions (Nacq) 1
Number of repetitions 60
Read direction Anterior–posterior
Slice locations Carotid bifurcation or stenosis
Scan time ∼52 sec
Table A1.3.6 Primary Clinical Imaging Parameters for Sequence 5 (3-D CE TOF)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Coronal
Central slice or volume center Centered on the carotid bifurcation
Echo time (TE) As short as possible (usually 2–3 msec)
Repeat time (TR) As short as possible (usually 4–8 msec)
Flip angle (FA) 10°–45°
Fields of view (FOVx, FOVy) 256 mm, 160 mm
Resolution (∆x, ∆y) 1 mm, 1 mm
Number of data points collected (Nx, Ny) 256, 160
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 2–3 mm
Number of slices 16–24, depending on the coverage
needed
Slab thickness 32–72 mm, depending on the coverage
needed
Slice gap 0 mm
Number of acquisitions (Nacq) 1
Read direction Cranial/caudal
Slice locations Centered along long axis of vessel of
interest to include vessel at all levels
required
Scan time ∼20–30 sec
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6. Start sequence 4 according to the parameters in Table A1.3.5 prior to injection so that
it runs continuously for ∼50 sec.
7. After 15 sec, start the injection so that the same data are collected prior to injection
for baseline purposes.
8. Find the image in which there is a maximum signal. Some systems come with
software to allow a region-of-interest plotted over all the sequence acquisitions.
Obtain the time when the signal is at maximum. This time indicates the scan delay
time.
A detailed estimation of the scan delay time is described in UNIT A10.1, Basic Protocol 2.
Sequence 5: Short TR 3-D gradient echo post-contrast scan
9. Let the patient know that you are ready to start the main scan and instruct the patient
to remain as motionless as possible.
10. Prepare the injector with a dose of 0.1 to 0.2 mmol/kg of contrast agent to be followed
by a 15- to 20-ml saline solution flush.
11. Inject the contrast agent and flush the saline solution. Wait for the scan delay time.
12. After obtaining the scan delay time, immediately start the scan according to the
parameters given in Table A1.3.6 so that the center of k-space corresponds to the peak
signal from the analysis in step 8.
The center of k-space should be used at the peak of the bolus. Preferably a centric ordered
elliptic k-space coverage will be used.
Waiting too long to start the scan will result in high signal from veins as well as arteries.
13. If a more detailed scan is needed to better visualize the vessels and time permits,
immediately collect a second, higher resolution scan by changing Nxfrom 256 to 512
and Nyfrom 160 to 320.
See Haacke and Masaryk (1989) for a discussion of this high-resolution scan.
The patient can then be removed from the magnet and the data analyzed.
BASIC
PROTOCOL 2
IMAGING BLOOD VESSEL WALLS BY SPIN-ECHO MRA
The inclusion of some sequences to study blood vessel walls after the vessels have been
imaged initially by time-of-flight MRA (see Basic Protocol 1) and an abnormality (e.g.,
stenosis) has been discovered is likely to become commonplace in the future. The simplest
approach for studying vessel-wall disease is to collect high-resolution images using a
spin-echo (SE) or turbo-spin-echo sequence (Yuan et al., 1996; Raynaud et al., 1998).
Although this is not yet a common procedure, it is anticipated that this will become part
of a single overall imaging protocol for evaluating carotid artery disease. The entire Basic
Protocol 2 takes ∼25 min.
Set up patient and equipment
1. Repeat Basic Protocol 1, steps 1 to 10.
Sequence 6: High-resolution spin-echo scan
2. Run a spin-echo sequence using the parameters described in Table A1.3.7 to obtain
vessel-wall information and general morphological information about the vessels and
surrounding tissue.
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COMMENTARY
Background Information
Atherosclerosis of the carotid artery is an
important medical condition because it is asso-
ciated with strokes, the third-greatest cause of
death in the United States. Obtaining detailed
information about carotid artery stenosis (nar-
rowing) can be critical to the determination of
appropriate treatment, e.g., data from the North
American Symptomatic Carotid Endarterec-
tomy Trial (NASCET) indicated that in patients
with symptomatic carotid stenosis of >70%, the
incidence of stroke was lower in patients treated
with surgery than in those receiving medical
care only. The traditional means of imaging
stenosis has been the invasive technique of
carotid angiography. More recently, ultrasound
has been suggested as a non-invasive alterna-
tive, but numerous studies have demonstrated
that it is less accurate. Magnetic resonance
angiography (MRA) is another non-invasive
technique—based, like ultrasound, on the de-
tection of flow through the artery. The related
imaging technique of contrast-enhanced MRA,
on the other hand, does not depend on the
presence of significant blood flow and may, in
the future, prove to be the most accurate means
of assessing the vessel lumen. Both of these
potentially complementary methods are pre-
sented in this unit (see Basic Protocol 1; see
Alternate Protocol). Common indications for
performing carotid MRA include transient is-
chemic attacks, stroke, neck injuries, suspicion
of carotid dissection, neck tumors, tumor inva-
sion of the carotid artery, carotid bruit on clini-
cal exam, or abnormal ultrasound screening
results prior to carotid bypass surgery. Other
methods for imaging blood vessels include ul-
trasound and computed tomography angiogra-
phy (CTA). Ultrasound provides good imaging
results only for surface vessels, but can also
Table A1.3.7 Primary Clinical Imaging Parameters for Sequence 6 (2-D SE)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Centered on the abnormality of
interest (commonly at the skull base or
carotid bifurcation)
Echo time (TE) 15 msec
Repeat time (TR) 500–700 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 256 mm, 200 mm (or as small as
appropriate without significant
aliasing)
Resolution (∆x, ∆y) 0.5 mm, 1 mm
Number of data points collected (Nx, Ny) 512, 200
Display matrix (Dx, Dy) 512, 512
Slice thickness (∆z) 3 mm
Number of slices 10–20, if more slices are needed to
cover the region of interest, then the
scan can be repeated as necessary
Slice gap 0 mm
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Slice locations Centered about the abnormality
Saturation pulses Yes; caudal and cephalic (cranial)
thick slabs to saturate both arteries and
veins using parallel saturation bands
Fat suppression Yes (for carotid dissection)
Slice series Interleaved
Scan time ∼2 min, 30 sec
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give information about vessel-wall thickness.
CTA does about as good a job as MRA but
requires the use of ionizing radiation and a
contrast agent.
Critical Parameters and
Troubleshooting
Magnetic resonance angiography without
contrast agents works on the principle of de-
tecting enhanced signal from blood due to the
inflow of fresh spins (see UNIT B7.3 for more
technical details). For a given repeat time (TR),
the choice of flip angle determines not only the
available signal from the blood but also the
available contrast between the blood and sur-
rounding tissue. The faster the flow, the larger
the flip angle that can be used to optimize the
signal from the blood and suppress the signal
from background tissue. For small vessels, high
resolution is key to creating a successful MR
angiogram. This is also true for larger vessels
if it is important to quantify the degree of
stenosis. The actual application of the se-
quences presented in this unit may require some
modifications depending on the age of the pa-
tient, the exact region being evaluated, and the
time available for scanning. For example, new-
borns have very slow arterial flow, whereas in
children aged 2 to 10, flow is very fast, which
makes it possible to increase the slab thickness
without loss of vascular information. Elderly
patients often have tortuous vessels and slow
flow, possibly requiring contrast-enhanced
MRA. Patients with tight stenoses and rapid
flow (up to 4 m/sec) may demonstrate vessels
with signal dropout, where contrast-enhanced
imaging may also help. Artifacts in carotid
artery imaging pose significant problems for
the interpretation of results. Three common
classes of artifacts are discussed below; for
further information, any one of a number of
standard texts, such as Potchen et al. (1992),
may be consulted.
Saturation artifacts
As a patient ages, blood vessels can become
tortuous and blood flow significantly slows
relative to younger people. The winding of the
vessels can lead to retrograde flow in those
patients relative to the presumed upward direc-
tion and this can cause saturation on the 2-D
TOF sequence (see UNIT B7.3). This is less of a
problem with 3-D imaging, where a lower flip
angle is used along with a spatially variable
pulse to try and avoid this difficulty. Still, even
3-D images can suffer if the flow is too slow.
Also, a shorter echo time (TE) can often give
better results because it has better flow com-
pensation and reduced acceleration effects.
Signal loss artifacts with gradient echo
imaging
Signal loss in the vessels themselves can be
caused by insufficient velocity compensation.
This can be improved upon by running a veloc-
ity compensated sequence with a shorter echo
time. Significant signal loss throughout the
image or in a large local region in gradient-echo
imaging can be caused by the presence of small
amounts of metals, especially those containing
iron or nickel. Even iron particulates in clothing
can lead to giant gaps in the image. Removing
all clothing, jewelry, and mascara can help
avoid this problem.
Artifacts in post-contrast scanning
Two major problems can occur. If the 3-D
post-contrast scan is started too soon, only the
edges of the arteries will enhance. If it is started
too late, the veins may be as bright as the
arteries making the viewing of the data in the
MIP form very difficult. Ideally, when the tim-
ing is perfect, the arteries will be much brighter
than the veins and only the edges of the veins
will appear if at all.
Anticipated Results
The goal in studying the carotid vessels is
to diagnose the degree of narrowing and, if
possible, the damage to the vessel wall itself.
Magnetic resonance imaging offers the neces-
sary contrast to separate the vessels from other
tissue. Conventional 3-D TOF scans are gener-
ally effective for visualizing the carotid arteries
(see Fig. A1.3.2). With a resolution of 1 mm in
all three directions and possibly higher for
in-plane resolution, vessels are well delineated.
With the better modern gradients allowing
shorter echo times and less signal loss from
dephasing, stenoses can be seen clearly. In
principle, it is also possible to quantify the
vessel lumen (i.e., the extent of stenosis), al-
though approved software offering this feature
is not yet widely available from equipment
manufacturers. Using MRA, the carotid arter-
ies can be imaged with a cross-sectional reso-
lution of ∼0.5 mm by 0.5 mm, with a slice
thickness of 1 mm. This is sufficient to obtain
10 to 20 pixels across the vessel lumen. This
resolution then limits how accurately one can
quantify the stenosis. The use of contrast agents
to enhance resolution is now commonplace.
These agents reduce the T1 of the blood, leading
to a larger signal from blood relative to all other
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Figure A1.3.3 Images from a contrast-enhanced scan immediately after injection of the contrast
agent. Data was acquired coronally so that all vessels could be seen in projection mode. The
in-plane resolution is just high enough to show the diseased vessels. (A) A major stenosis is present
on the right carotid and some abnormality on the left carotid. (B) A magnified view of the right carotid
shows the latter problem more clearly.
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tissues independent of flow, so that the blood
will be bright even in cases of slow or ob-
structed flow. Immediately post injection, only
the arterial blood appears bright; after ∼30 sec,
the signal from venous blood begins to enhance
as well. The advantage of using a contrast agent
is the increased coverage and the rapid imaging
time (see Fig. A1.3.3). In-phase resolution is
sufficient to visualize severe stenoses easily.
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